The deubiquitinating enzyme USP1 regulates the Fanconi anemia pathway.

Protein ubiquitination and deubiquitination are dynamic processes implicated in the regulation of numerous cellular pathways. Monoubiquitination of the Fanconi anemia (FA) protein FANCD2 appears to be critical in the repair of DNA damage because many of the proteins that are mutated in FA are required for FANCD2 ubiquitination. By screening a gene family RNAi library, we identify the deubiquitinating enzyme USP1 as a novel component of the Fanconi anemia pathway. Inhibition of USP1 leads to hyperaccumulation of monoubiquitinated FANCD2. Furthermore, USP1 physically associates with FANCD2, and the proteins colocalize in chromatin after DNA damage. Finally, analysis of crosslinker-induced chromosomal aberrations in USP1 knockdown cells suggests a role in DNA repair. We propose that USP1 deubiquitinates FANCD2 when cells exit S phase or recommence cycling after a DNA damage insult and may play a critical role in the FA pathway by recycling FANCD2.

[1]  R. Bernards,et al.  Stable suppression of tumorigenicity by virus-mediated RNA interference. , 2002, Cancer cell.

[2]  Carlo Rago,et al.  Tumour suppression: Disruption of HAUSP gene stabilizes p53 , 2004, Nature.

[3]  S. Ganesan,et al.  Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. , 2001, Molecular cell.

[4]  A. D’Andrea,et al.  ATR couples FANCD2 monoubiquitination to the DNA-damage response. , 2004, Genes & development.

[5]  C. Mathew,et al.  Bi‐allelic silencing of the Fanconi anaemia gene FANCF in acute myeloid leukaemia , 2003, British journal of haematology.

[6]  Hans Joenje,et al.  Biallelic Inactivation of BRCA2 in Fanconi Anemia , 2002, Science.

[7]  Yuan-Tsong Chen,et al.  A marker for Stevens–Johnson syndrome , 2004 .

[8]  C. Chung,et al.  Deubiquitinating enzymes as cellular regulators. , 2003, Journal of biochemistry.

[9]  A. D’Andrea The Fanconi road to cancer. , 2003, Genes & development.

[10]  Susan M. Gordon,et al.  Fanconi anemia protein complex: mapping protein interactions in the yeast 2- and 3-hybrid systems. , 2003, Blood.

[11]  M. Loda,et al.  The isopeptidase USP2a regulates the stability of fatty acid synthase in prostate cancer. , 2004, Cancer cell.

[12]  D. Pellman,et al.  Deubiquitinating enzymes: a new class of biological regulators. , 1998, Critical reviews in biochemistry and molecular biology.

[13]  A. Auerbach,et al.  International Fanconi Anemia Registry: relation of clinical symptoms to diepoxybutane sensitivity. , 1989 .

[14]  C. Mathew,et al.  Heterogeneity in Fanconi anemia: evidence for 2 new genetic subtypes. , 2004, Blood.

[15]  Weidong Wang,et al.  A Multiprotein Nuclear Complex Connects Fanconi Anemia and Bloom Syndrome , 2003, Molecular and Cellular Biology.

[16]  C. Mathew,et al.  Disruption of the Fanconi anemia–BRCA pathway in cisplatin-sensitive ovarian tumors , 2003, Nature Medicine.

[17]  C. Bishop,et al.  A novel ubiquitin ligase is deficient in Fanconi anemia , 2003, Nature Genetics.

[18]  S. H. Baek,et al.  Deubiquitinating enzymes: their diversity and emerging roles. , 1999, Biochemical and biophysical research communications.

[19]  H. Mohrenweiser,et al.  Hypomutability in Fanconi anemia cells is associated with increased deletion frequency at the HPRT locus. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[20]  K Tanaka,et al.  Identification and chromosomal assignment of USP1, a novel gene encoding a human ubiquitin-specific protease. , 1998, Genomics.

[21]  A. D’Andrea,et al.  S-phase-specific interaction of the Fanconi anemia protein, FANCD2, with BRCA1 and RAD51. , 2002, Blood.

[22]  C. Ball,et al.  Identification of genes periodically expressed in the human cell cycle and their expression in tumors. , 2002, Molecular biology of the cell.

[23]  K. Wilkinson Ubiquitination and deubiquitination: targeting of proteins for degradation by the proteasome. , 2000, Seminars in cell & developmental biology.

[24]  Hans Joenje,et al.  FANCE: the link between Fanconi anaemia complex assembly and activity , 2002, The EMBO journal.

[25]  M. Yamaizumi,et al.  Multiple roles of Rev3, the catalytic subunit of polζ in maintaining genome stability in vertebrates , 2003, The EMBO journal.

[26]  K. J. Patel,et al.  The Fanconi anaemia gene FANCC promotes homologous recombination and error-prone DNA repair. , 2004, Molecular cell.

[27]  R. Bernards,et al.  A System for Stable Expression of Short Interfering RNAs in Mammalian Cells , 2002, Science.

[28]  A. D’Andrea,et al.  Functional Interaction of Monoubiquitinated FANCD2 and BRCA2/FANCD1 in Chromatin , 2004, Molecular and Cellular Biology.

[29]  G. Courtois,et al.  The tumour suppressor CYLD negatively regulates NF-κB signalling by deubiquitination , 2003, Nature.

[30]  René Bernards,et al.  Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-κB , 2003, Nature.

[31]  F. R. Papa,et al.  The yeast DOA4 gene encodes a deubiquitinating enzyme related to a product of the human tre-2 oncogene , 1993, Nature.

[32]  G. Pals,et al.  X-linked inheritance of Fanconi anemia complementation group B , 2004, Nature Genetics.

[33]  A. Ashworth,et al.  CYLD is a deubiquitinating enzyme that negatively regulates NF-κB activation by TNFR family members , 2003, Nature.

[34]  Jennifer L. Harris,et al.  Substrate profiling of deubiquitin hydrolases with a positional scanning library and mass spectrometry. , 2004, Biochemistry.

[35]  C. Mathew,et al.  Interaction of FANCD2 and NBS1 in the DNA damage response , 2002, Nature Cell Biology.

[36]  R. Bernards,et al.  Distinct Initiation and Maintenance Mechanisms Cooperate to Induce G1 Cell Cycle Arrest in Response to DNA Damage , 2000, Cell.

[37]  Bo Xu,et al.  Convergence of the Fanconi Anemia and Ataxia Telangiectasia Signaling Pathways , 2002, Cell.

[38]  J. Qin,et al.  Deubiquitination of p53 by HAUSP is an important pathway for p53 stabilization , 2002, Nature.

[39]  J. Pagano,et al.  Tumor Viruses and Cell Signaling Pathways: Deubiquitination versus Ubiquitination , 2004, Molecular and Cellular Biology.

[40]  Q. Waisfisz,et al.  The Fanconi anemia protein FANCF forms a nuclear complex with FANCA, FANCC and FANCG. , 2000, Human molecular genetics.